Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

CureVac N.V. - Ordinary Shares (NQ:CVAC)

4.660 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	0
Open	4.660
Bid (Size)	4.500 (100)
Ask (Size)	4.820 (200)
Prev. Close	4.660
Today's Range	4.660 - 4.660
52wk Range	4.000 - 5.550
Shares Outstanding	223,988,675
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

BioNTech Navigates Post-Pandemic Deficit: A €17 Billion Bet on the Oncology Frontier

March 10, 2026

In a watershed moment for the biotechnology sector, BioNTech SE (NASDAQ: BNTX) has reported its full-year 2025 financial results, signaling the definitive end of the COVID-19 vaccine gold rush and the...

Via MarketMinute

BioNTech Finalizes CureVac Acquisition: A Strategic Consolidation Met with Market Skepticism

January 09, 2026

In a move that signals the end of an era for independent mRNA pioneers, BioNTech SE (Nasdaq: BNTX) has officially completed its acquisition of longtime rival CureVac N.V. (Nasdaq: CVAC). The...

Via MarketMinute

Performance

52-Week Range 16.0% below 52-week high

4.660

4.0052W Low 5.5552W High

CureVac N.V. - Ordinary Shares (CVAC) traded between $4.00 and $5.55 over the past 52 weeks and last traded at $4.66, 16.0% below its 52-week high.

Past 12 Months

N/A

-0.2%

-13.9%

YTD -$0.01

1Y -$0.75

CVAC was -13.9% over the past year, -0.2% year to date.

12 Months vs Market

CVAC

-13.9%

DIA

+9.7%

SPY

+15.4%

QQQ

+24.4%

IWM

+14.8%

Over the past 12 months CVAC returned -13.9% versus DIA (Dow) +9.7%, SPY (S&P 500) +15.4%, QQQ (Nasdaq 100) +24.4% and IWM (Russell 2000) +14.8%.

Volume & Liquidity

YTD

774.1K

1.1M

More News

CureVac Announces Voting Results of Extraordinary General Meeting

November 25, 2025

Via ACCESS Newswire

CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates

November 24, 2025

Via ACCESS Newswire

CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates

August 15, 2025

Via ACCESS Newswire

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth ↗

August 04, 2025

Via Benzinga

Cooling US Bird Flu Wave Removes Tailwind For Moderna, Novavax, CureVac, Traws Pharma ↗

July 08, 2025

Via Stocktwits

This Trade Desk Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗

June 26, 2025

Via Benzinga

CureVac Announces Voting Results of General Meeting

June 24, 2025

Via ACCESS Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders

June 20, 2025

From Halper Sadeh LLC

Via GlobeNewswire

5 Stocks To Ride The German Market Rally ↗

June 16, 2025

Via Benzinga

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVAC, KNW, SOAR, HLGN on Behalf of Shareholders

June 13, 2025

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)

June 13, 2025

From Brodsky & Smith LLC

Via GlobeNewswire

This Sherwin-Williams Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday ↗

June 13, 2025

Via Benzinga

Market Monitor News June 13 (Oracle UP - Gamestop DOWN) ↗

June 13, 2025

Via Chartmill

Here are the top movers in Thursday's session. ↗

June 12, 2025

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

June 12, 2025

Via Chartmill

Nasdaq Moves Higher; Oracle Shares Jump After Upbeat Q4 Results ↗

June 12, 2025

Via Benzinga

BioNTech Expands mRNA Cancer Portfolio With CureVac $1.25 Billion All-Stock Deal ↗

June 12, 2025

Via Benzinga

CureVac, TELUS International, Oracle And Other Big Stocks Moving Higher On Thursday ↗

June 12, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

June 12, 2025

Via Chartmill

BioNTech To Acquire CureVac In All-Stock Deal Valued At $1.25B: Retail Sees Breakthrough In Cancer Treatment ↗

June 12, 2025

Via Stocktwits

CVAC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of CureVac N.V. Is Fair to Shareholders

June 12, 2025

From Halper Sadeh LLC

Via Business Wire

Wondering what's happening in today's pre-market session? ↗

June 12, 2025

Via Chartmill

Trump Administration Terminates $590 Million Moderna Bird Flu Vaccine Deal, Dismantling Biden-Era Pandemic Preparedness Effort ↗

May 29, 2025

Via Benzinga

Frequently Asked Questions

Is CureVac N.V. - Ordinary Shares publicly traded?

Yes, CureVac N.V. - Ordinary Shares is publicly traded.

What exchange does CureVac N.V. - Ordinary Shares trade on?

CureVac N.V. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for CureVac N.V. - Ordinary Shares?

The ticker symbol for CureVac N.V. - Ordinary Shares is CVAC on the Nasdaq Stock Market

What is the current price of CureVac N.V. - Ordinary Shares?

The current price of CureVac N.V. - Ordinary Shares is 4.660

When was CureVac N.V. - Ordinary Shares last traded?

The last trade of CureVac N.V. - Ordinary Shares was at 01/05/26 04:00 PM ET

What is the market capitalization of CureVac N.V. - Ordinary Shares?

The market capitalization of CureVac N.V. - Ordinary Shares is 1.04B

How many shares of CureVac N.V. - Ordinary Shares are outstanding?

CureVac N.V. - Ordinary Shares has 1B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.